News
Is it MS? Survey Results
The Multiple Sclerosis International Federation (MSIF) has published the results of its ‘Is it MS?’ survey. The survey was carried out in early 2012 with over 4000 people taking part, sharing their experience of being diagnosed with MS.
Carers Strategy Launched
Carers’ wellbeing, confidence and health are at the heart of the new National Carers Strategy. For carers in Ireland, this means recognition and acknowledgement of their role as key care partners.
Gallop: MS Video
The wonderful people over at shift.ms have created this fantastic video – watch here.
FDA Consider Alemtuzumab
For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and the European Medicines Agency (EMA).
Leading neurologist praises the role of the NAI
In an article in today's Health Supplement, Professor Orla Hardiman, Consultant Neurologist and world leading researcher into motor neurone disease praised the role of the NAI as a "pivotal force for improving neurological care services in Ireland".
Gilenya Now Prescribed
Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individuals with highly active MS.
Your Space, Your Say!
The MS Ireland blog is your space to talk about the things that matter to you. It's an opportunity to come together with a community of like-minded people and share your stories, advice and tips.